Topic Areas

Topic Areas

Topic Areas on NINDS

Frontotemporal Lobar Degeneration (FTD) includes a complex group of clinical syndromes (behavioral variant FTD, semantic variant primary progressive aphasia, nonfluent/agrammatic variant primary progressive aphasia, logopenic variant primary progressive aphasia, FTD with motor neuron disease, progressive supranuclear palsy syndrome, Pick’s Disease and cortical basal syndrome) and this variation in clinical presentation, in part, defines the complexity of the FTLD sequencing project.  In addition to the clinical presentation, the proteinopathies (tau, TDP43, progranulin, fus, C9ORF72) associ

The goal of the 'SCI 2020: Launching a Decade for Disruption in Spinal Cord Injury Research' conference is to initiate discussion across the SCI research community to launch a new decade of research that disrupts traditional barriers and brings about collaborative efforts to address the key research questions in spinal cord injury research.  This conference is designed to be a comprehensive stakeholder’s meeting to bring diverse experience and voices together with this common goal.  The participants will be challenged to critically evaluate the state of the science

Topic Area(s):

This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs will also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to NDD.

Now in its 11th year, the Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry including pharmaceuticals, medical devices, software and diagnostics for the brain and nervous system.

Organized by the Neurotechnology Industry Organization and our partner NeuroInsights, the 11th annual conference will be held on Wednesday and Thursday, April 6-7, 2016 at The Westin Boston Waterfront, Boston, MA.

The European Congress on Epileptology (ECE) is now a landmark in the epilepsy community agenda and the Prague 2016 promises to be innovative and engaging.

Topic Area(s):

The 13th Eilat Conference on New Antiepileptic Drugs and Devices will be introducing debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments. 

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One Partnering™ meetings.

On May 30th – May 31st, 2019, the NIH Pain Consortium will convene the 14th Annual NIH Pain Consortium Symposium on Advances in Pain Research. The symposium: “Pain Across the Lifespan,” will feature a keynote address by Drs. Anne Case and Sir Angus Deaton of Princeton University, entitled “Pain and Opioids in an Epidemic of Mental and Economic Distress.”

Topic Area(s):

Over 100 NIH SBIR and STTR program managers and federal staffers, including representatives from the Centers for Disease Control (CDC) and Food and Drug Administration (FDA), along with 500 health and science managers, entrepreneurs, business executives, non-profit and university researchers, and consulting organizations will convene in Seattle for this important conference.

The NINDS Udall Centers of Excellence program was established in 1997 in tandem with the passage of the Morris K. Udall Parkinson’s Disease Research Act (P.L 105-78).  The primary programmatic goal is to define the causes of and discover improved treatments for Parkinson’s disease (PD).  In 2017, eight Udall Centers pursued high-impact multidisciplinary research, shared research resources and data, and provided active outreach to local patient and advocacy communities.